NCT00491686View on ClinicalTrials.gov

AZD6765 for Treatment Resistant Depression

PHASE2CompletedINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Depression

Interventions

DRUG

AZD6765

intravenous infusion

Trial Locations (5)

Unknown

Research Site, Glendale

Research Site, Hartford

Research Site, New Haven

Research Site, Wichita

Research Site, Rockville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY